Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story.
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder with a multifactorial etiology. Latest researches are raising the hypothesis of a link between the onset of the main behavioral symptoms of ASD and the chronic neuroinflammatory condition of the autistic brain; increasing evidence of this connection is shedding light on new possible players in the pathogenesis of ASD. The endocannabinoid system (ECS) has a key role in neurodevelopment as well as in normal inflammatory responses and it is not surprising that many preclinical and clinical studies account for alterations of the endocannabinoid signaling in ASD. These findings lay the foundation for a better understanding of the neurochemical mechanisms underlying ASD and for new therapeutic attempts aimed at exploiting the renowned anti-inflammatory properties of cannabinoids to treat pathologies encompassed in the autistic spectrum. This review discusses the current preclinical and clinical evidence supporting a key role of the ECS in the neuroinflammatory state that characterizes ASD, providing hints to identify new biomarkers in ASD and promising therapies for the future.
Keywords: Autism spectrum disorder; cannabidiol; cannabinoids; endocannabinoid system; microglia; neuroinflammation.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats.
Front Cell Neurosci. 2019 Aug 9;13:367. doi: 10.3389/fncel.2019.00367. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31447649 Free PMC article.
2020 Jun 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. StatPearls. 2020 Jan–. PMID: 32491480 Free Books & Documents. Review.
Lower circulating endocannabinoid levels in children with autism spectrum disorder.
Mol Autism. 2019 Jan 30;10:2. doi: 10.1186/s13229-019-0256-6. eCollection 2019. Mol Autism. 2019. PMID: 30728928 Free PMC article.
Convergent evidence for mGluR5 in synaptic and neuroinflammatory pathways implicated in ASD.
Neurosci Biobehav Rev. 2015 May;52:172-7. doi: 10.1016/j.neubiorev.2015.02.006. Epub 2015 Feb 19. Neurosci Biobehav Rev. 2015. PMID: 25704074 Review.
Impaired neurodevelopmental pathways in autism spectrum disorder: a review of signaling mechanisms and crosstalk.
J Neurodev Disord. 2019 Jun 15;11(1):10. doi: 10.1186/s11689-019-9268-y. J Neurodev Disord. 2019. PMID: 31202261 Free PMC article. Review.